ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
JohnnyBlue
|
2.0K |
621K |
1 |
23/09/20 |
23/09/20 |
ASX - By Stock
|
2.0K
|
621K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia new collaboration with Dana-Farber Cancer Institute
|
|
JohnnyBlue
|
41 |
10K |
2 |
22/09/20 |
22/09/20 |
ASX - By Stock
|
41
|
10K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
OS, PFS, QOL
|
|
JohnnyBlue
|
20 |
5.4K |
6 |
17/09/20 |
17/09/20 |
ASX - By Stock
|
20
|
5.4K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
OS, PFS, QOL
|
|
JohnnyBlue
|
20 |
5.4K |
7 |
17/09/20 |
17/09/20 |
ASX - By Stock
|
20
|
5.4K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia presents to H C Wainwright conference
|
|
JohnnyBlue
|
33 |
8.3K |
4 |
16/09/20 |
16/09/20 |
ASX - By Stock
|
33
|
8.3K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia presents to H C Wainwright conference
|
|
JohnnyBlue
|
33 |
8.3K |
10 |
16/09/20 |
16/09/20 |
ASX - By Stock
|
33
|
8.3K
|
10
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia presents to H C Wainwright conference
|
|
JohnnyBlue
|
33 |
8.3K |
3 |
16/09/20 |
16/09/20 |
ASX - By Stock
|
33
|
8.3K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Paxalisib GBM Interim data Abstract at SNO Virtual 19-21 November 2020
|
|
JohnnyBlue
|
27 |
7.1K |
6 |
16/09/20 |
16/09/20 |
ASX - By Stock
|
27
|
7.1K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
KZA Chart
|
|
JohnnyBlue
|
559 |
156K |
7 |
09/09/20 |
09/09/20 |
ASX - By Stock
|
559
|
156K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
Effects of PI3K Inhibition on Peripheral Leukocytes in Metastatic Breast Cancer
|
|
JohnnyBlue
|
68 |
15K |
2 |
08/09/20 |
08/09/20 |
ASX - By Stock
|
68
|
15K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Effects of PI3K Inhibition on Peripheral Leukocytes in Metastatic Breast Cancer
|
|
JohnnyBlue
|
68 |
15K |
3 |
07/09/20 |
07/09/20 |
ASX - By Stock
|
68
|
15K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
JohnnyBlue
|
2.0K |
621K |
4 |
30/08/20 |
30/08/20 |
ASX - By Stock
|
2.0K
|
621K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Change in substantial holding
|
|
JohnnyBlue
|
22 |
6.8K |
3 |
21/08/20 |
21/08/20 |
ASX - By Stock
|
22
|
6.8K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia's paxalisib granted Fast Track Designation by FDA
|
|
JohnnyBlue
|
66 |
21K |
1 |
21/08/20 |
21/08/20 |
ASX - By Stock
|
66
|
21K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia's paxalisib granted Fast Track Designation by FDA
|
|
JohnnyBlue
|
66 |
21K |
6 |
21/08/20 |
21/08/20 |
ASX - By Stock
|
66
|
21K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Alliance A071701: Genomically guided treatment trial in brain metastases.
|
|
JohnnyBlue
|
40 |
12K |
3 |
15/08/20 |
15/08/20 |
ASX - By Stock
|
40
|
12K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Alliance A071701: Genomically guided treatment trial in brain metastases.
|
|
JohnnyBlue
|
40 |
12K |
0 |
15/08/20 |
15/08/20 |
ASX - By Stock
|
40
|
12K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Alliance A071701: Genomically guided treatment trial in brain metastases.
|
|
JohnnyBlue
|
40 |
12K |
0 |
15/08/20 |
15/08/20 |
ASX - By Stock
|
40
|
12K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Alliance A071701: Genomically guided treatment trial in brain metastases.
|
|
JohnnyBlue
|
40 |
12K |
0 |
15/08/20 |
15/08/20 |
ASX - By Stock
|
40
|
12K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Alliance A071701: Genomically guided treatment trial in brain metastases.
|
|
JohnnyBlue
|
40 |
12K |
0 |
15/08/20 |
15/08/20 |
ASX - By Stock
|
40
|
12K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Alliance A071701: Genomically guided treatment trial in brain metastases.
|
|
JohnnyBlue
|
40 |
12K |
1 |
15/08/20 |
15/08/20 |
ASX - By Stock
|
40
|
12K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Across the pond...Nasdaq: KZIA
|
|
JohnnyBlue
|
270 |
75K |
1 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
270
|
75K
|
1
|
|
ASX - By Stock
|
KZA |
Price Action
|
|
JohnnyBlue
|
14 |
3.8K |
2 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
14
|
3.8K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
JohnnyBlue
|
2.0K |
621K |
3 |
09/08/20 |
09/08/20 |
ASX - By Stock
|
2.0K
|
621K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
JohnnyBlue
|
2.0K |
621K |
4 |
08/08/20 |
08/08/20 |
ASX - By Stock
|
2.0K
|
621K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia's paxalisib obtains Rare Pediatric Disease Designation
|
|
JohnnyBlue
|
102 |
33K |
4 |
07/08/20 |
07/08/20 |
ASX - By Stock
|
102
|
33K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
KZA Chart
|
|
JohnnyBlue
|
559 |
156K |
3 |
04/08/20 |
04/08/20 |
ASX - By Stock
|
559
|
156K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
KZA Chart
|
|
JohnnyBlue
|
559 |
156K |
2 |
04/08/20 |
04/08/20 |
ASX - By Stock
|
559
|
156K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Appendix 4C - quarterly
|
|
JohnnyBlue
|
32 |
6.8K |
3 |
03/08/20 |
03/08/20 |
ASX - By Stock
|
32
|
6.8K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
JohnnyBlue
|
2.0K |
621K |
0 |
17/07/20 |
17/07/20 |
ASX - By Stock
|
2.0K
|
621K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Across the pond...Nasdaq: KZIA
|
|
JohnnyBlue
|
270 |
75K |
3 |
17/07/20 |
17/07/20 |
ASX - By Stock
|
270
|
75K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
KAZIA
|
|
JohnnyBlue
|
15 |
3.7K |
2 |
04/07/20 |
04/07/20 |
ASX - By Stock
|
15
|
3.7K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
EOFY Sale
|
|
JohnnyBlue
|
19 |
4.3K |
3 |
02/07/20 |
02/07/20 |
ASX - By Stock
|
19
|
4.3K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
EOFY Sale
|
|
JohnnyBlue
|
19 |
4.3K |
3 |
02/07/20 |
02/07/20 |
ASX - By Stock
|
19
|
4.3K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Nasdaq
|
|
JohnnyBlue
|
23 |
6.6K |
2 |
23/06/20 |
23/06/20 |
ASX - By Stock
|
23
|
6.6K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Nasdaq
|
|
JohnnyBlue
|
23 |
6.6K |
7 |
23/06/20 |
23/06/20 |
ASX - By Stock
|
23
|
6.6K
|
7
|
|
ASX - By Stock
|
KZA |
Nasdaq
|
|
JohnnyBlue
|
23 |
6.6K |
10 |
16/06/20 |
16/06/20 |
ASX - By Stock
|
23
|
6.6K
|
10
|
|
ASX - By Stock
|
KZA |
Re:
Extreme Chronic Undervalue
|
|
JohnnyBlue
|
228 |
57K |
4 |
12/06/20 |
12/06/20 |
ASX - By Stock
|
228
|
57K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Extreme Chronic Undervalue
|
|
JohnnyBlue
|
228 |
57K |
4 |
11/06/20 |
11/06/20 |
ASX - By Stock
|
228
|
57K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Extreme Chronic Undervalue
|
|
JohnnyBlue
|
228 |
57K |
1 |
11/06/20 |
11/06/20 |
ASX - By Stock
|
228
|
57K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Extreme Chronic Undervalue
|
|
JohnnyBlue
|
228 |
57K |
0 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
228
|
57K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Extreme Chronic Undervalue
|
|
JohnnyBlue
|
228 |
57K |
0 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
228
|
57K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Extreme Chronic Undervalue
|
|
JohnnyBlue
|
228 |
57K |
0 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
228
|
57K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Extreme Chronic Undervalue
|
|
JohnnyBlue
|
228 |
57K |
7 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
228
|
57K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
Extreme Chronic Undervalue
|
|
JohnnyBlue
|
228 |
57K |
2 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
228
|
57K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Extreme Chronic Undervalue
|
|
JohnnyBlue
|
228 |
57K |
2 |
09/06/20 |
09/06/20 |
ASX - By Stock
|
228
|
57K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
JohnnyBlue
|
2.0K |
621K |
2 |
03/06/20 |
03/06/20 |
ASX - By Stock
|
2.0K
|
621K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
ASCO
|
|
JohnnyBlue
|
24 |
6.4K |
2 |
02/06/20 |
02/06/20 |
ASX - By Stock
|
24
|
6.4K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
ASCO
|
|
JohnnyBlue
|
24 |
6.4K |
1 |
02/06/20 |
02/06/20 |
ASX - By Stock
|
24
|
6.4K
|
1
|
|
ASX - By Stock
|
KZA |
ASCO
|
|
JohnnyBlue
|
24 |
6.4K |
2 |
02/06/20 |
02/06/20 |
ASX - By Stock
|
24
|
6.4K
|
2
|
|